N
Nan Haw Chow
Researcher at National Cheng Kung University
Publications - 155
Citations - 5498
Nan Haw Chow is an academic researcher from National Cheng Kung University. The author has contributed to research in topics: Cancer & Transitional cell carcinoma. The author has an hindex of 35, co-authored 148 publications receiving 5121 citations. Previous affiliations of Nan Haw Chow include Johns Hopkins University & Johns Hopkins University School of Medicine.
Papers
More filters
Journal ArticleDOI
Stable-isotope dimethyl labeling for quantitative proteomics.
TL;DR: A novel, stable-isotope labeling strategy for quantitative proteomics that uses a simple reagent, formaldehyde, to globally label the N-terminus and epsilon-amino group of Lys through reductive amination is reported.
Journal Article
Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.
Paul Cairns,Manel Esteller,James G. Herman,Mark P. Schoenberg,Carmen Jerónimo,Montserrat Sanchez-Cespedes,Nan Haw Chow,Marc E. Grasso,Li Wu,William B. Westra,David Sidransky +10 more
TL;DR: It is demonstrated that molecular diagnosis of prostate neoplasia in urine is feasible and larger studies focusing on carcinoma size, location in the prostate, and urine collection techniques, as well as more sensitive technology, may lead to the useful application of GSTP1 hypermethylation in prostate cancer diagnosis and management.
Journal ArticleDOI
Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients.
TL;DR: The results suggest that VEGF may play a role in the progression of colon cancer, although evaluation of this angiogenic phenotype did not provide additional prognostic information compared with that obtained from Dukes' staging of the tumours.
Journal Article
Expression Profiles of ErbB Family Receptors and Prognosis in Primary Transitional Cell Carcinoma of the Urinary Bladder
TL;DR: Examination of expression patterns of ErbB receptors by immunohistochemistry in primary human bladder cancer and compared with conventional biological indicators indicates that a combination of EGFR, Er bB2, and ErbbB3 expression profile may be a better prognostic indicator than any family member alone.
Journal ArticleDOI
Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients.
TL;DR: Co-expression of RON and MET seems to signify an aggressive phenotype in node-negative breast cancer patients.